Test Your Knowledge Diabetes In Control.com Issue #185

This Week’s Question: Comes from this weeks newsletter Item#2 Combining rosiglitazone, metformin, and insulin aspart improved glucose metabolism in obese type 2 diabetic patients compared with mixed insulin alone, according to the results of a open-label, randomized trial published in the December issue of Diabetes Care. Which of the following would not be a benefit of the above triple therapy?